Skip to main content

Advertisement

Log in

Erectile dysfunction as a cardiovascular risk factor in patients with diabetes

  • Review
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Erectile dysfunction (ED) is a highly prevalent disorder among patients with diabetes mellitus (DM). In most cases, ED is considered a vascular disease and its development is significantly related to the exposure to CVD risk factors. In this context, ED and coronary artery disease (CAD) have been proposed as different manifestations of the same systemic disease; in nondiabetic patients, ED has progressively emerged as an important sentinel marker of the subsequent onset of CVD events. The aim of this review was to evaluate the association between ED and CAD in diabetic patients and to evaluate the role of ED as an independent CVD risk factor in these patients. Three large prospective studies confirmed that ED is a powerful predictor of CAD and cardiac mortality in patients with DM. Overall, diabetic patients with ED had roughly 1.4-fold higher risk of CAD as compared with those without ED. Interestingly, in diabetic patients, CAD is often silent and CAD screening according to the current guidelines can miss up to 40 % patients with occult myocardial perfusion abnormalities. Indeed, patients with ED have higher risk of silent myocardial ischemia compared to those without ED, and when ED is added to the risk factors, it can even improve the sensitivity of screening for asymptomatic CAD. Therefore, ED should be considered an independent CVD risk factor, and it could improve the identification of diabetic patients suitable for screening, leading to an early detection of CAD, and thus potentially enhancing the therapeutic effectiveness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA, 270, 83–90 (1993)

  2. R.W. Lewis, K.S. Fugl-Meyer, G. Corona, R.D. Hayes, E.O. Laumann, E.D. Moreira Jr, A.H. Rellini, T. Segraves, Definitions/epidemiology/risk factors for sexual dysfunction. J. Sex. Med. 7, 1598–1607 (2010)

    Article  PubMed  Google Scholar 

  3. G. Corona, D.M. Lee, G. Forti, D.B. O’Connor, M. Maggi, T.W. O’Neill, N. Pendleton, G. Bartfai, S. Boonen, F.F. Casanueva, J.D. Finn, A. Giwercman, T.S. Han, I.T. Huhtaniemi, K. Kula, M.E. Lean, M. Punab, A.J. Silman, D. Vanderschueren, F.C. Wu, EMAS Study Group: age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). J. Sex. Med. 7, 1362–1380 (2010)

    Article  PubMed  Google Scholar 

  4. J. De Almeida Claro, O.G. Kaufmann, G. Alarcon, W. Aguiar, A. Nadozza Jr, V. Ortiz, M. Srougi, Could a rural lifestyle decrease the prevalence of erectile dysfunction? BJU Int. 99, 127–129 (2007)

    Article  PubMed  Google Scholar 

  5. N.M. Gades, A. Nehra, D.J. Jacobson, M.E. McGree, C.J. Girman, T. Rhodes, R.O. Roberts, M.M. Lieber, S.J. Jacobsen, Association between smoking and erectile dysfunction: a population-based study. Am. J. Epidemiol. 161, 346–351 (2005)

    Article  PubMed  Google Scholar 

  6. B.P. Gupta, M.H. Murad, M.M. Clifton, L. Prokop, A. Nehra, S.L. Kopecky, The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch. Intern. Med. 171, 1797–1803 (2011)

    Article  PubMed  Google Scholar 

  7. S.R. Fine, Erectile dysfunction and comorbid diseases, androgen deficiency, and diminished libido in men. J. Am. Osteopath. Assoc. 104, S9–S15 (2004)

    PubMed  Google Scholar 

  8. C. Gazzaruso, S. Giordanetti, E. De Amici, G. Bertone, C. Falcone, D. Geroldi, P. Fratino, S.B. Solerte, A. Garzaniti, Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 110, 22–26 (2004)

    Article  PubMed  Google Scholar 

  9. J. Hidalgo-Tamola, K. Chitaley, Review type 2 diabetes mellitus and erectile dysfunction. J. Sex. Med. 6, 916–926 (2009)

    Article  PubMed  CAS  Google Scholar 

  10. H.A. Feldman, I. Goldstein, D.G. Hatzichristou, R.J. Krane, J.B. McKinlay, Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol. 151, 54–61 (1994)

    PubMed  CAS  Google Scholar 

  11. F.A. Giuliano, A. Leriche, E.O. Jaudinot, A.S. de Gendre, Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology 64, 1196–1201 (2004)

    Article  PubMed  Google Scholar 

  12. J.P. Burke, D.J. Jacobson, M.E. McGree, A. Nehra, R.O. Roberts, C.J. Girman, M.M. Lieber, S.J. Jacobsen, Diabetes and sexual dysfunction: results from the Olmsted County study of urinary symptoms and health status among men. J. Urol. 177, 1438–1442 (2007)

    Article  PubMed  Google Scholar 

  13. A. Al-Hunayan, M. Al-Mutar, E.O. Kehinde, L. Thalib, M. Al-Ghorory, The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus. BJU Int. 99, 130–134 (2007)

    Article  PubMed  Google Scholar 

  14. G. Yang, C. Pan, J. Lu, Prevalence of erectile dysfunction among Chinese men with type 2 diabetes mellitus. Int. J. Impot. Res. 22, 310–317 (2010)

    Article  PubMed  CAS  Google Scholar 

  15. R. Klein, B.E. Klein, K.E. Lee, S.E. Moss, K.J. Cruickshanks, Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care 19, 135–141 (1996)

    Article  PubMed  CAS  Google Scholar 

  16. O. Kalter-Leibovici, J. Wainstein, A. Ziv, I. Harman-Bohem, H. Murad, I. Raz, Israel Diabetes Research Group (IDRG) Investigators, Clinical, socioeconomic, and lifestyle parameters associated with erectile dysfunction among diabetic men. Diabetes Care 28, 1739–1744 (2005)

    Article  PubMed  Google Scholar 

  17. W.B. Kannel, D.L. McGee, Diabetes and cardiovascular disease. The Framingham study. JAMA 241, 2035–2038 (1979)

    Article  PubMed  CAS  Google Scholar 

  18. S.M. Grundy, I.J. Benjamin, G.L. Burke, A. Chait, R.H. Eckel, B.V. Howard, W. Mitch, S.C. Smith Jr, J.R. Sowers, Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100, 1134–1146 (1999)

    Article  PubMed  CAS  Google Scholar 

  19. C.M. Alexander, P.B. Landsman, S.M. Teutsch, Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease. Am. J. Card. 86, 897–902 (2000)

    Article  PubMed  CAS  Google Scholar 

  20. R. Scognamiglio, C. Negut, A. Ramondo, A. Tiengo, A. Avogaro, Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J. Am. Coll. Cardiol. 47, 65–71 (2006)

    Article  PubMed  Google Scholar 

  21. F.J. Wackers, L.H. Young, S.E. Inzucchi, D.A. Chyun, J.A. Davey, E.J. Barrett, R. Taillefer, S.D. Wittlin, G.V. Heller, N. Filipchuk, S. Engel, R.E. Ratner, A.E. Iskandrian, Detection of ischemia in asymptomatic diabetics Investigators: detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27, 1954–1961 (2004)

    Article  PubMed  Google Scholar 

  22. S. Stern, Symptoms other than chest pain may be important in the diagnosis of “silent ischemia,” or “the sounds of silence”. Circulation 111, e435–e437 (2005)

    Article  PubMed  Google Scholar 

  23. American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. Diabetes care 21, 1551–1559 (1998)

  24. C. Gazzaruso, A. Coppola, T. Montalcini, C. Valenti, A. Garzaniti, G. Pelissero, F. Salvucci, P. Gallotti, A. Pujia, C. Falcone, S.B. Solerte, A. Giustina, Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes. Endocrine 40, 273–279 (2011)

    Article  PubMed  CAS  Google Scholar 

  25. F.J. Wackers, Asymptomatic patients with diabetes mellitus should be screened for coronary artery disease. J. Nucl. Cardiol. 13, 609–615 (2006)

    Article  PubMed  Google Scholar 

  26. R.C. Ma, W.Y. So, X. Yang, L.W. Yu, A.P. Kong, G.T. Ko, C.C. Chow, C.S. Cockram, J.C. Chan, P.C. Tong, Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J. Am. Coll. Cardiol. 51, 2045–2050 (2008)

    Article  PubMed  Google Scholar 

  27. K. García-Malpartida, R. Mármol, A. Jover, M.J. Gómez-Martínez, E. Solá-Izquierdo, V.M. Victor, M. Rocha, D. Sanmiguel, A. Hernández-Mijares, Relationship between erectile dysfunction and silent myocardial ischemia in type 2 diabetic patients with no known macrovascular complications. J. Sex. Med. 8, 2606–2616 (2011)

    Article  PubMed  Google Scholar 

  28. T.D. Miller, R.F. Redberg, F.J. Wackers, Screening asymptomatic diabetic patients for coronary artery disease: why not? J. Am. Coll. Cardiol. 48, 761–764 (2006)

    Article  PubMed  Google Scholar 

  29. G.A. Beller, Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic type 2 diabetic patients: is it appropriate and cost-effective? J. Am. Coll. Cardiol. 49, 1918–1923 (2007)

    Article  PubMed  Google Scholar 

  30. E. Faglia, M. Mantero, A. Quarantiello, M. Gino, V. Curci, M. Caminiti, R. Mattioli, A. Morabito, Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study. Am. Heart J. 149, e1–e6 (2005)

    Article  PubMed  Google Scholar 

  31. L.H. Young, F.J. Wackers, D.A. Chyun, J.A. Davey, E.J. Barrett, R. Taillefer, G.V. Heller, A.E. Iskandrian, S.D. Wittlin, N. Filipchuk, R.E. Ratner, S.E. Inzucchi, DIAD Investigators, Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 301, 1547–1555 (2009)

    Article  PubMed  CAS  Google Scholar 

  32. C. Gazzaruso, A. Coppola, T. Montalcini, C. Valenti, G. Pelissero, S.B. Solerte, F. Salvucci, P. Gallotti, A. Pujia, A. Garzaniti, A. Giustina, Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients. Intern. Emerg. Med. 7, 257–266 (2012)

    Article  PubMed  Google Scholar 

  33. O.H. Franco, E.W. Steyerberg, F.B. Hu, J. Mackenbach, W. Nusselder, Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch. Intern. Med. 167, 1145–1151 (2007)

    Article  PubMed  Google Scholar 

  34. M. Laakso, Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48, 937–942 (1999)

    Article  PubMed  CAS  Google Scholar 

  35. K. Gu, C.C. Cowie, M.I. Harris, Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993. Diabetes Care 21, 1138–1145 (1998)

    Article  PubMed  CAS  Google Scholar 

  36. S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyörälä, M. Laakso, Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339, 229–234 (1998)

    Article  PubMed  CAS  Google Scholar 

  37. S. Yamagishi, Cardiovascular disease in recent onset diabetes mellitus. J. Cardiol. 57, 257–262 (2011)

    Article  PubMed  Google Scholar 

  38. W.D. Rosamond, L.E. Chambless, A.R. Folsom, L.S. Cooper, D.E. Conwill, L. Clegg, C.H. Wang, G. Heiss, Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N. Engl. J. Med. 339, 861–867 (1998)

    Article  PubMed  CAS  Google Scholar 

  39. J.H. Lee, R. Ngengwe, P. Jones, F. Tang, J.H. O’Keefe, Erectile dysfunction as a coronary artery disease risk equivalent. J. Nucl. Cardiol. 15, 800–803 (2008)

    PubMed  Google Scholar 

  40. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Eng. J. Med. 329, 977–86 (1993)

    Google Scholar 

  41. P.J. Savage, Cardiovascular complications of diabetes mellitus: what we know and what we need to know about their prevention. Ann. Intern. Med. 124, 123–126 (1996)

    PubMed  CAS  Google Scholar 

  42. M. Chiariello, C. Indolfi, M.R. Cotecchia, C. Sifola, M. Romano, M. Condorelli, Asymptomatic transient ST changes during ambulatory ECG monitoring in diabetic patients. Am. Heart J. 110, 529–534 (1985)

    Article  PubMed  CAS  Google Scholar 

  43. O. May, H. Arildsen, E.M. Damsgaard, H. Mickley, Prevalence and prediction of silent ischaemia in diabetes mellitus: a population-based study. Cardiovasc. Res. 34, 241–247 (1997)

    Article  PubMed  CAS  Google Scholar 

  44. P. Valensi, E. Cosson, It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia. Diabetes Metab. 36, 91–96 (2010)

    Article  PubMed  CAS  Google Scholar 

  45. J.Y. Dong, Y.H. Zhang, L.Q. Qin, Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J. Am. Coll. Cardiol. 58, 1378–1385 (2011)

    Article  PubMed  Google Scholar 

  46. W. Guo, C. Liao, Y. Zou, F. Li, T. Li, Q. Zhou, Y. Cao, X. Mao, Erectile dysfunction and risk of clinical cardiovascular events: a meta-analysis of seven cohort studies. J. Sex. Med. 7, 2805–2816 (2010)

    Article  PubMed  Google Scholar 

  47. S.T. Chang, C.M. Chu, J.F. Hsiao, C.M. Chung, J.J. Shee, C.S. Chen, J.T. Hsu, Coronary phenotypes in patients with erectile dysfunction and silent ischemic heart disease: a pilot study. J. Sex. Med. 7, 2798–2804 (2010)

    Article  PubMed  Google Scholar 

  48. C. Gratzke, J. Angulo, K. Chitaley, Y.T. Dai, N.N. Kim, J.S. Paick, U. Simonsen, S. Uckert, E. Wespes, K.E. Andersson, T.F. Lue, C.G. Stief, Anatomy, physiology, and pathophysiology of erectile dysfunction. J. Sex. Med. 7, 445–475 (2010)

    Article  PubMed  CAS  Google Scholar 

  49. K.L. Billups, A.J. Bank, H. Padma-Nathan, S.D. Katz, R.A. Williams, Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int. J. Impot. Res. 20, 236–242 (2008)

    Article  PubMed  CAS  Google Scholar 

  50. G. Jackson, P. Montorsi, M.A. Adams, T. Anis, A. El-Sakka, M. Miner, C. Vlachopoulos, E. Kim, Cardiovascular aspects of sexual medicine. J. Sex. Med. 7, 1608–1626 (2010)

    Article  PubMed  Google Scholar 

  51. F. Montorsi, A. Briganti, A. Salonia, P. Rigatti, A. Margonato, A. Macchi, S. Galli, P.M. Ravagnani, P. Montorsi, Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur. Urol. 44, 360–364 (2003)

    Article  PubMed  Google Scholar 

  52. R.A. Kloner, S.H. Mullin, T. Shook, R. Matthews, G. Mayeda, S. Burstein, H. Peled, C. Pollick, R. Choudhary, R. Rosen, H. Padma-Nathan, Erectile dysfunction in the cardiac patient: how common and should we treat? J. Urol. 170, S46–S50 (2003)

    Article  PubMed  Google Scholar 

  53. P. Montorsi, P.M. Ravagnani, S. Galli, A. Salonia, A. Briganti, J.P. Werba, F. Montorsi, Association between erectile dysfunction and coronary artery disease: matching the right target with the right test in the right patient. Eur. Urol. 50, 721–731 (2006)

    Article  PubMed  Google Scholar 

  54. H. Solomon, J.W. Man, G. Jackson, Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 89, 251–253 (2003)

    Article  PubMed  CAS  Google Scholar 

  55. J. Araña Rosaínz Mde, M.O. Ojeda, J.R. Acosta, L.C. Elías-Calles, N.O. González, O.T. Herrera, C.T. García Álvarez, E.M. Rodríguez, M.E. Báez, E.Á. Seijas, R.F. Valdés, Imbalanced low-grade inflammation and endothelial activation in patients with type 2 diabetes mellitus and erectile dysfunction. J. Sex. Med. 8, 2017–2030 (2011)

    Article  PubMed  Google Scholar 

  56. P. Montorsi, P.M. Ravagnani, S. Galli, F. Rotatori, A. Briganti, A. Salonia, P. Rigatti, F. Montorsi, The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am. J. Cardiol. 96, 19M–23M (2005)

    Article  PubMed  Google Scholar 

  57. I.M. Thompson, C.M. Tangen, P.J. Goodman, J.L. Probstfield, C.M. Moinpour, C.A. Coltman, Erectile dysfunction and subsequent cardiovascular disease. JAMA 294, 2996–3002 (2005)

    Article  PubMed  CAS  Google Scholar 

  58. A.B. Araujo, T.G. Travison, P. Ganz, G.R. Chiu, V. Kupelian, R.C. Rosen, S.A. Hall, J.B. McKinlay, Erectile dysfunction and mortality. J. Sex. Med. 6, 2445–2454 (2009)

    Article  PubMed  Google Scholar 

  59. G. Corona, M. Monami, V. Boddi, M. Cameron-Smith, F. Lotti, G. de Vita, C. Melani, D. Balzi, A. Sforza, G. Forti, E. Mannucci, M. Maggi, Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction. J. Sex. Med. 7, 1918–1927 (2010)

    Article  PubMed  Google Scholar 

  60. A. Ponholzer, C. Temml, R. Obermayr, C. Wehrberger, S. Madersbacher, Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur. Urol. 48, 512–518 (2005)

    Article  PubMed  Google Scholar 

  61. P. Montorsi, P.M. Ravagnani, S. Galli, F. Rotatori, F. Veglia, A. Briganti, A. Salonia, F. Dehò, P. Rigatti, F. Montorsi, C. Fiorentini, Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur. Heart J. 27, 2632–2639 (2006)

    Article  PubMed  Google Scholar 

  62. E. Chiurlia, R. D’Amico, C. Ratti, A.R. Granata, R. Romagnoli, M.G. Modena, Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J. Am. Coll. Cardiol. 46, 1503–1506 (2005)

    Article  PubMed  Google Scholar 

  63. C. Gazzaruso, S.B. Solerte, A. Pujia, A. Coppola, M. Vezzoli, F. Salvucci, C. Valenti, A. Giustina, A. Garzaniti, Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. J. Am. Coll. Cardiol. 51, 2040–2044 (2008)

    Article  PubMed  Google Scholar 

  64. G.D. Batty, Q. Li, S. Czernichow, B. Neal, S. Zoungas, R. Huxley, A. Patel, B.E. de Galan, M. Woodward, P. Hamet, S.B. Harrap, N. Poulter, J. Chalmers, ADVANCE Collaborative Group, Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. J. Am. Coll. Cardiol. 56, 1908–1913 (2010)

    Article  PubMed  Google Scholar 

  65. R.J. Heruti, I. Uri, Y. Arbel, M. Swartzon, S. Galor, D. Justo, Erectile dysfunction severity might be associated with poor cardiovascular prognosis in diabetic men. J. Sex. Med. 4, 465–471 (2007)

    Article  PubMed  Google Scholar 

  66. B.L. Meena, D.K. Kochar, T.D. Agarwal, R. Choudhary, A. Kochar, Association between erectile dysfunction and cardiovascular risk in individuals with type-2 diabetes without overt cardiovascular disease. Int. J. Diabetes Dev. Ctries. 29, 150–154 (2009)

    Article  PubMed  Google Scholar 

  67. C. Gazzaruso, A. Pujia, S.B. Solerte, E.D. Amici, E. Emanuele, C. Falcone, D. Geroldi, A. Giustina, A. Garzaniti, Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients. Int. J. Impot. Res. 18, 311–315 (2006)

    Article  PubMed  CAS  Google Scholar 

  68. P.F. Cohn, Prognosis for patients with different types of silent coronary artery disease. Circulation 75, II33–II35 (1987)

    PubMed  CAS  Google Scholar 

  69. M.K. Gaba, S. Gaba, L.T. Clark, Cardiovascular disease in patients with diabetes: clinical considerations. J. Assoc. Acad. Minor. Phys. 10, 15–22 (1999)

    PubMed  CAS  Google Scholar 

  70. D.E. Price, J.C. Gingell, S. Gepi-Attee, K. Wareham, P. Yates, M. Boolell, Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men. Diabet. Med. 15, 821–825 (1998)

    Article  PubMed  CAS  Google Scholar 

  71. K. Hatzimouratidis, E. Amar, I. Eardley, F. Giuliano, D. Hatzichristou, F. Montorsi, Y. Vardi, E. Wespes, European Association of Urology, Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur. Urol. 57, 804–814 (2010)

    Article  PubMed  Google Scholar 

  72. I. Saenz de Tejada, Molecular mechanisms for the regulation of penile smooth muscle contractility. Int. J. Impot. Res. 14, S6–S10 (2002)

    Article  PubMed  Google Scholar 

  73. B.G. Schwartz, L.A. Levine, G. Comstock, V.J. Stecher, R.A. Kloner, Cardiac uses of phosphodiesterase-5 inhibitors. J. Am. Coll. Cardiol. 59, 9–15 (2012)

    Article  PubMed  CAS  Google Scholar 

  74. M. Jamnicki-Abegg, D. Weihrauch, P.C. Chiari, J.G. Krolikowski, P.S. Pagel, D.C. Warltier, J.R. Kersten, Diabetes abolishes sildenafil-induced cGMP-dependent protein kinase-I expression and cardioprotection. J. Cardiovasc. Pharmacol. 50, 670–676 (2007)

    Article  PubMed  CAS  Google Scholar 

  75. M. Madhani, A.R. Hall, F. Cuello, R.L. Charles, J.R. Burgoyne, W. Fuller, A.J. Hobbs, M.J. Shattock, P. Eaton, Phospholemman Ser69 phosphorylation contributes to sildenafil-induced cardioprotection against reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 299, H827–H836 (2010)

    Article  PubMed  CAS  Google Scholar 

  76. F.N. Salloum, A. Abbate, A. Das, J.E. Houser, C.A. Mudrick, I.Z. Qureshi, N.N. Hoke, S.K. Roy, W.R. Brown, S. Prabhakar, R.C. Kukreja, Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice. Am. J. Physiol. Heart. Circ. Physiol. 294, H1398–H1406 (2008)

    Article  PubMed  CAS  Google Scholar 

  77. F.N. Salloum, Y. Takenoshita, R.A. Ockaili, V.P. Daoud, E. Chou, K. Yoshida, R.C. Kukreja, Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits. J. Mol. Cell. Cardiol. 42, 453–458 (2007)

    Article  PubMed  CAS  Google Scholar 

  78. S. Rosanio, Y. Ye, S. Atar, A.M. Rahman, S.Y. Freeberg, M.H. Huang, B.F. Uretsky, Y. Birnbaum, Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin. Cardiovasc. Drugs Ther. 20, 27–36 (2006)

    Article  PubMed  CAS  Google Scholar 

  79. K.K. Chew, J. Finn, B. Stuckey, N. Gibson, F. Sanfilippo, A. Bremner, P. Thompson, M. Hobbs, K. Jamrozik, Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linked-data study. J. Sex. Med. 7, 192–202 (2010)

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesco Montorsi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gandaglia, G., Salonia, A., Passoni, N. et al. Erectile dysfunction as a cardiovascular risk factor in patients with diabetes. Endocrine 43, 285–292 (2013). https://doi.org/10.1007/s12020-012-9780-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-012-9780-2

Keywords

Navigation